Literature DB >> 26916919

Polygonum multiflorum Decreases Airway Allergic Symptoms in a Murine Model of Asthma.

Chen-Chen Lee1,2,3,4, Yueh-Lun Lee1, Chien-N Wang2, Hsing-Chuan Tsai5, Chun-Lung Chiu5, Leroy F Liu6, Hung-Yun Lin6, Reen Wu5.   

Abstract

The root of Polygonum multiflorum (also called He-Shou-Wu in Chinese) is a common herb and medicinal food in Asia used for its anti-aging properties. Our study investigated the therapeutic potential of an extract of the root of Polygonum multiflorum (PME) in allergic asthma by using a mouse model. Feeding of 0.5 and 1 mg/mouse PME inhibited ovalbumin (OVA)-induced allergic asthma symptoms, including airway inflammation, mucus production, and airway hyper-responsiveness (AHR), in a dose-dependent manner. To discern PME's mechanism of action, we examined the profile and cytokine production of inflammatory cells in bronchial alveolar lavage fluid (BALF). We found that eosinophils, the main inflammatory cell infiltrate in the lung of OVA-immunized mice, significantly decreased after PME treatment. Th2 cytokine levels, including interleukin (IL)-4, IL-5, IL-13, eotaxin, and the proinflammatory cytokine tumor necrosis factor (TNF)-[Formula: see text], decreased in PME-treated mice. Elevated mRNA expression of Th2 transcription factor GATA-3 in the lung tissue was also inhibited after oral feeding of PME in OVA-immunized mice. Thus, we conclude that PME produces anti-asthma activity through the inhibition of Th2 cell activation.

Entities:  

Keywords:  Airway Hyper-Responsiveness; Airway Inflammation; Polygonum multiflorum; Th2

Mesh:

Substances:

Year:  2016        PMID: 26916919     DOI: 10.1142/S0192415X16500099

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  1 in total

1.  Efficacy and Safety of Runzao Zhiyang Capsule as an Add-On Therapy for Chronic Eczema: A Systematic Review and Meta-Analysis.

Authors:  Ming Li; Boyang Zhou; Lihong Zhou; Linfeng Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-03-17       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.